Trial Profile
A Phase IV Clinical Trial of Intensified Blood Pressure Management in Primary Care Using Valsartan Alone and as Combination Anti-Hypertensive Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Hydrochlorothiazide (Primary) ; Valsartan (Primary) ; Valsartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms VIPER-BP
- Sponsors Novartis
- 22 Nov 2012 Results published in the BMJ.
- 15 Dec 2011 Results published in the International Journal of Cardiology.
- 07 Jun 2011 Planned End Date changed from 1 Mar 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.